Modulation of structured polypeptide specificity
US11912794B2 · kind B2 · utility
0Cited by
15References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2020 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | Jun 11, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes peptide ligands specific for human plasma Kallikrein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.